Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00090987
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
NETWORK
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
imatinib mesylate
Sponsor
AIDS Malignancy Consortium
Collaborators
[object Object]
[object Object]